4-176115829-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_181265.4(WDR17):c.157G>A(p.Ala53Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000131 in 1,605,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000012 ( 0 hom. )
Consequence
WDR17
NM_181265.4 missense
NM_181265.4 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 4.15
Genes affected
WDR17 (HGNC:16661): (WD repeat domain 17) This gene encodes a WD repeat-containing protein. It is abundantly expressed in retina and testis, and is thought to be a candidate gene for retinal disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.3278665).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR17 | NM_181265.4 | c.157G>A | p.Ala53Thr | missense_variant | 3/29 | ENST00000508596.6 | NP_851782.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR17 | ENST00000508596.6 | c.157G>A | p.Ala53Thr | missense_variant | 3/29 | 1 | NM_181265.4 | ENSP00000422763 | P1 | |
WDR17 | ENST00000280190.8 | c.229G>A | p.Ala77Thr | missense_variant | 4/31 | 1 | ENSP00000280190 | |||
WDR17 | ENST00000507824.6 | c.229G>A | p.Ala77Thr | missense_variant | 3/30 | 5 | ENSP00000422200 | |||
WDR17 | ENST00000513261.1 | c.196-4038G>A | intron_variant, NMD_transcript_variant | 3 | ENSP00000427502 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151418Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
3
AN:
151418
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000404 AC: 10AN: 247620Hom.: 0 AF XY: 0.0000299 AC XY: 4AN XY: 133994
GnomAD3 exomes
AF:
AC:
10
AN:
247620
Hom.:
AF XY:
AC XY:
4
AN XY:
133994
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1453912Hom.: 0 Cov.: 30 AF XY: 0.00000830 AC XY: 6AN XY: 723152
GnomAD4 exome
AF:
AC:
18
AN:
1453912
Hom.:
Cov.:
30
AF XY:
AC XY:
6
AN XY:
723152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000198 AC: 3AN: 151418Hom.: 0 Cov.: 32 AF XY: 0.0000406 AC XY: 3AN XY: 73910
GnomAD4 genome
AF:
AC:
3
AN:
151418
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
73910
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2022 | The c.229G>A (p.A77T) alteration is located in exon 4 (coding exon 3) of the WDR17 gene. This alteration results from a G to A substitution at nucleotide position 229, causing the alanine (A) at amino acid position 77 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N;.
MutationTaster
Benign
D;D;D;D
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
0.98, 0.91
.;D;P
Vest4
MVP
MPC
0.51
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at